Five-year survival of patients treated for esophageal cancer at the Institute of Oncology in Ljubljana in the years 1960-1989.

In last decades, the incidence of esophageal cancer in the male as well as female population of Slovenia has been increasing moderately. The number of long-term survivals is rather low. The treatment results of 13/714 (1.

Treatment of advanced esophageal cancer by means of irradiation, cisplatinum and 5-fluorouracil.

In the years 1985-1990, 30 patients with locally advanced and/or disseminated cancer of the esophagus (Stages III and IV) were treated by radiotherapy (RT) and chemotherapy (ChT) containing cisplatinum and 5-fluorouracil (5-FU). The median survival of the patients was 8 months (range 2.5-39 months); 13 Stage III patients survived 3-36 months respectively (median 11 months), while 17 Stage IV patients survived 2.